InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,567.19
(
1.06%
)
US TECH 100
19,828.00
(
0.95%
)
Dow Jones
39,375.87
(
0.17%
)
Brent Oil
86.78
(
0.00%
)
Bitcoin
57,753.34
(
-0.94%
)
Post# of 30335
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

QuicKtip

Send PM Follow Ignore
Followers 17
Posts 3857
Boards Moderated 2
Alias Born 08/23/2022

QuicKtip

Re: None

Monday, 06/03/2024 1:30:45 PM

Monday, June 03, 2024 1:30:45 PM

Post# of 30335
$AIMD Ainos = AI + Nose

Ainos, Inc. (Nasdaq: AIMD) develops novel point-of-care testing (POCT), low-dose VELDONA interferon therapeutics, and synthetic RNA-driven preventative medicine. The company’s products include VELDONA clinical-stage human therapeutics, VELDONA Pet Cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform.

twitter: https://twitter.com/AinosInc
#AinosInc

Stocks On High ALert

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up